Patil R - Search Results

1

Effects, in an in-vivo model system, of 1,2,3,4-tetrahydroisoquinoline on glioma.

Kang GS, Wang XD, Mohler ML, Kirichenko OV, Patil R, Orr WE, Miller DD, Geisert EE. Kang GS, et al. Among authors: patil r. Anticancer Drugs. 2008 Oct;19(9):859-70. doi: 10.1097/CAD.0b013e32830d5887. Anticancer Drugs. 2008. PMID: 18766000

2

Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.

Mohler ML, Kang GS, Hong SS, Patil R, Kirichenko OV, Li W, Rakov IM, Geisert EE, Miller DD. Mohler ML, et al. Among authors: patil r. J Med Chem. 2006 Sep 21;49(19):5845-8. doi: 10.1021/jm060020x. J Med Chem. 2006. PMID: 16970409

3

Treating retinoblastoma in tissue culture and in a rat model with a novel isoquinoline derivative.

Nassr M, Wang X, Mitra S, Freeman-Anderson NE, Patil R, Yates CR, Miller DD, Geisert EE. Nassr M, et al. Among authors: patil r. Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3813-9. doi: 10.1167/iovs.09-5042. Invest Ophthalmol Vis Sci. 2010. PMID: 20570997

4

EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo.

Wang XD, Freeman NE, Patil R, Patil SA, Mitra S, Orr WE, Abner CW, Yates CR, Miller DD, Geisert EE. Wang XD, et al. Among authors: patil sa, patil r. Anticancer Drugs. 2012 Jun;23(5):494-504. doi: 10.1097/CAD.0b013e328351ee4f. Anticancer Drugs. 2012. PMID: 22391460

5

Plasma and cerebrospinal fluid pharmacokinetics of the novel tetrahydroisoquinoline EDL-155 in rats.

Song P, Ma F, Wang F, Wang X, Patil R, Ramagiri S, Orr WE, Miller DD, Geisert E, Yates CR. Song P, et al. Among authors: patil r. Cancer Chemother Pharmacol. 2008 May;61(6):1037-44. doi: 10.1007/s00280-007-0563-z. Epub 2007 Sep 1. Cancer Chemother Pharmacol. 2008. PMID: 17768626

6

Fast and sensitive liquid chromatography/electrospray mass spectrometry method to study ocular penetration of EDL-155, a novel antitumor agent for retinoblastoma in rats.

Ramagiri S, Ma F, Kosanam H, Wang X, Patil R, Miller DD, Geisert E, Yates CR. Ramagiri S, et al. Among authors: patil r. J Mass Spectrom. 2009 May;44(5):786-93. doi: 10.1002/jms.1556. J Mass Spectrom. 2009. PMID: 19160451

7

Novel approaches to glioma drug design and drug screening.

Patil SA, Hosni-Ahmed A, Jones TS, Patil R, Pfeffer LM, Miller DD. Patil SA, et al. Among authors: patil r. Expert Opin Drug Discov. 2013 Sep;8(9):1135-51. doi: 10.1517/17460441.2013.807248. Epub 2013 Jun 6. Expert Opin Drug Discov. 2013. PMID: 23738794 Review.

8

Chromenes: potential new chemotherapeutic agents for cancer.

Patil SA, Patil R, Pfeffer LM, Miller DD. Patil SA, et al. Among authors: patil r. Future Med Chem. 2013 Sep;5(14):1647-60. doi: 10.4155/fmc.13.126. Future Med Chem. 2013. PMID: 24047270 Review.

9

Synthesis and in vitro evaluation of novel 1,2,3,4-tetrahydroisoquinoline derivatives as potent antiglioma agents.

Patil R, Hosni-Ahmed A, Jones TS, Patil SA, Asres LB, Wang X, Yates RC, Geisert EE, Miller DD. Patil R, et al. Among authors: patil sa. Anticancer Agents Med Chem. 2014 Mar;14(3):473-82. doi: 10.2174/18715206113139990328. Anticancer Agents Med Chem. 2014. PMID: 24533653

10

Cesium fluoride and tetra-n-butylammonium fluoride mediated 1,4-N-->O shift of disubstituted phenyl ring of a bicalutamide derivative.

Patil R, Li W, Ross CR, Kraka E, Cremer D, Mohler ML, Dalton JT, Miller DD. Patil R, et al. Tetrahedron Lett. 2006 Jun 5;47(23):3941-3944. doi: 10.1016/j.tetlet.2006.03.154. Tetrahedron Lett. 2006. PMID: 18079983 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,468 results

Search Page

Filters